Major shareholder announcement
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments.
Per September 2, 2024, BlackRock, Inc. has adjusted its holding of shares to an equivalent of 23,377,683 shares, corresponding to 4.99% (previously 5.12%) of the total share capital attached to shares. The combined total of share capital attached to shares and share capital through financial instruments is 5.01%.
Attachments


Upcoming Life Sciences Events
- February 2025
- Biotechgate Digital Partnering February 2025
- Zurich: 18th Annual European Life Sciences CEO Forum
- March 2025
- Miami: Investival Showcase USA
Latest company news
There are currently no news available for this portal